| Literature DB >> 22940000 |
Susan A Masino1, Masahito Kawamura, Jessica L Cote, Rebecca B Williams, David N Ruskin.
Abstract
In rodents, insufficient adenosine produces behavioral and physiological symptoms consistent with several comorbidities of autism. In rodents and humans, stimuli postulated to increase adenosine can ameliorate these comorbidities. Because adenosine is a broad homeostatic regulator of cell function and nervous system activity, increasing adenosine's influence might be a new therapeutic target for autism with multiple beneficial effects. This article is part of the Special Issue entitled 'Neurodevelopmental Disorders'.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22940000 PMCID: PMC3529135 DOI: 10.1016/j.neuropharm.2012.08.013
Source DB: PubMed Journal: Neuropharmacology ISSN: 0028-3908 Impact factor: 5.250